Thomas Guiel
Vermögen: 15 657 $ am 31.05.2026
Vermögen: 15 657 $ am 31.05.2026
Mr. Thomas G.
Guiel is a Chief Operating Officer at Oxford BioDynamics Plc.
Mr. Guiel was previously employed as a Principal by Invitrogen Corp., a Chief Operating Officer & Executive Vice President by OncoPlex Diagnostics, Inc., and a Vice President-Operations by OpGen, Inc.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OXFORD BIODYNAMICS PLC 0,15 % | 10.11.2025 | 6 288 146 ( 0,15 % ) | 15 657 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| OXFORD BIODYNAMICS PLC | Geschäftsführer | - |
| Unternehmen | Position | Ende |
|---|---|---|
OncoPlex Diagnostics, Inc.
OncoPlex Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates a cancer diagnostics laboratory | Geschäftsführer | 01.01.2018 |
| CAPFORCE INC. | Geschäftsführer | - |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and sells life science research kits and provides research services | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and sells life science research kits and provides research services | Electronic Technology |
OpGen, Inc.
OpGen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies against life-threatening, antibiotic-resistant infections using molecular diagnostics and bioinformatics | Commercial Services |
OncoPlex Diagnostics, Inc.
OncoPlex Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates a cancer diagnostics laboratory | Health Services |
Oxford BioDynamics Plc
Oxford BioDynamics Plc BiotechnologyHealth Technology Discovers and develops novel biomarkers | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen